PatiePatient Dies After Taking Relenza Anti viral
Saturday, October 10, 2009
Patient Dies After Taking Relenza Anti viral
As Glaxo orders point to big flu vaccine windfall .The drugs company GlaxoSmith Kline said that at least one person has died after turning its anti-flu powder Relenza into a liquid.
In a letter to doctors, GSK said reformulation was not recommended by the Food and Drug Administration in the US. The FDA posted the letter online yesterday without providing details of the person who died.
Relenza comes in powder form for use with Glaxo’s Diskhaler device. The drug is approved to treat symptoms of the seasonal flu when taken within two days of onset.
The FDA and London-based GSK have stressed that reconstituting Relenza has not been established as safe.
0 comments:
Post a Comment